Kaul Siddharth — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Kaul Siddharth has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Profile
Kaul Siddharth is identified in Immunocore Holdings plc's SEC filings as a person associated with the company as of 2026-05-28. The available information does not clearly specify the exact role (for example, director, officer, or other insider). Immunocore Holdings plc is a biotechnology company focused on immune-oncology and other T-cell receptor therapies. This entry provides a provisional biographical sketch based on the SEC context; please verify with official Immunocore disclosures (e.g., annual reports, Form 6-K/other filings) for precise role, background, and tenure.
Kaul Siddharth is identified in Immunocore Holdings plc's SEC filings as a person associated with the company as of 2026-05-28. The available information does not clearly specify the exact role (for example, director, officer, or other insider). Immunocore Holdings plc is a biotechnology company focused on immune-oncology and other T-cell receptor therapies. This entry provides…
How many SEC Form 4 filings has Kaul Siddharth submitted recently?
1 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of Kaul Siddharth's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
